According to a recent LinkedIn post from vopemed, the company is present at The American Society of Colon and Rectal Surgeons Annual Scientific Meeting, engaging attendees from an industry-focused booth hosted by Arthrex. The post highlights vopemed’s CLARIS system, described as a real-time digital desmoking technology intended for minimally invasive surgery.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn post suggests that CLARIS is aimed at addressing persistent visualization challenges in the operating room caused by surgical smoke plume and other obstructions. It further indicates that the technology is designed to integrate into existing surgical workflows while helping surgeons maintain a consistent view during procedures.
As shared in the post, vopemed’s CEO and Co-Founder, Amy, and Operations Lead, Jessica, are attending the event to connect with surgeons and industry collaborators and to gather feedback on CLARIS. This emphasis on direct clinician engagement may signal an effort to refine product-market fit and accelerate clinical adoption within the colorectal and broader minimally invasive surgery segments.
For investors, the visibility at a major specialty meeting and collaboration with an established player like Arthrex could enhance vopemed’s credibility in the MedTech and surgical innovation space. If CLARIS achieves meaningful adoption, the focus on real-time desmoking and workflow compatibility could position the company to benefit from growing demand for visualization-enhancing tools in minimally invasive and AI-enabled surgical environments.